Philip Home

16PUBLICATIONS
17CO-AUTHORS
Immunogenetics (incl. genetic immunology)Industrial biotechnology diagnostics (incl. biosensors)Information systems development methodologies and practiceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 03, 2025
Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta-analysis of non-Asian studies.

Philip Home, Felipe Lauand, Khier Djaballah

|Mar 21, 2025
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes.

Geremia B Bolli, Philip D Home, Francesca Porcellati

|Mar 04, 2025
An overview of insulin therapy for the non-specialist.

Philip D Home

|Aug 17, 2021
Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison.

Philip D Home, Roopa Mehta, Khadija A S Hafidh

|Jul 24, 2020
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.

Philip Home, Lawrence Blonde, Sanjay Kalra

|Jul 07, 2020
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.

Philip D Home, Vanita R Aroda, Lawrence Blonde

Pageof 3

Frequent Collaborators

3 joint publications

Lawrence Blonde

2 joint publications

Matthew C Riddle

2 joint publications

Michael F Crutchlow

2 joint publications

Julio Rosenstock